[多发性硬化症患者下肢肌适应性过载综合征]
F A Khabirov1, D Kh Khaybullina1, N N Babicheva2
1Kazan State Medical Academy - branch of the Russian Medical Academy of Continuing Professional Education, Kazan, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|August 8, 2025
概括
多发性硬化症 (MS) 中的慢性疼痛通常与脊柱生物力学问题和肌适应性过载综合征 (MOSs) 有关. 结合药物治疗和物理治疗的综合方法对于治疗疼痛和改善多发性硬化患者的生活质量至关重要.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 疼痛管理 疼痛管理
背景情况:
- 慢性疼痛是多发性硬化症 (MS) 患者面临的重大挑战.
- 由于脊柱生物力学障碍和肌适应性过载综合征 (MOSs) 引起的 nociceptive 疼痛是一个关键问题.
- 肌肉骨过载导致MS患者的疼痛慢性化和生活质量下降.
研究的目的:
- 分析MS患者肌肉骨过载的致病机制.
- 突出脊柱生物力学和MOSs在慢性疼痛发展中的作用.
- 倡导MS相关疼痛的综合诊断和治疗策略.
主要方法:
- 姿势和代理机制的病原遗传分析.
- 评估生物力学障碍 (,性高性,脊柱形).
- 对MS疼痛管理现有文献的综述.
主要成果:
- 脊柱生物力学障碍和MOS是MS中可感性疼痛的重要贡献者.
- 这些因素加剧疼痛,减少运动活动,并损害生活质量.
- 这项研究强调了姿势,肌肉过载和慢性疼痛进展之间的联系.
结论:
- 综合性方法对于治疗多发性硬化症慢性疼痛至关重要.
- 治疗应结合药理干预措施与纠正生物力学障碍.
- 运动治疗和软手动技术是这种综合方法的重要组成部分.
相关概念视频
Cross-bridge Cycle
118.3K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.3K
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35


